Citation: Ick. Wong et al., Adverse event monitoring in lamotrigine patients: A pharmacoepidemiologic study in the United Kingdom, EPILEPSIA, 42(2), 2001, pp. 237-244
Authors:
Wong, ICK
Mawer, GE
Sander, JWAS
Lhatoo, SD
Citation: Ick. Wong et al., A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy, EPILEPSIA, 42(10), 2001, pp. 1354-1358
Citation: D. Sweis et Ick. Wong, A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain, DRUG SAFETY, 23(2), 2000, pp. 165-172
Authors:
Lhatoo, SD
Wong, ICK
Polizzi, G
Sander, JWAS
Citation: Sd. Lhatoo et al., Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy, EPILEPSIA, 41(12), 2000, pp. 1592-1596
Citation: Ick. Wong et al., The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy, EPILEPSIA, 40(10), 1999, pp. 1439-1445